Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
17198 participants
OBSERVATIONAL
2013-01-31
2040-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrial Fibrillation General Registry
NCT02518984
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
NCT01119716
PREdicting Atrial Fibrillation or Flutter
NCT01851902
Atrial Fibrillation Ablation Registry
NCT04055961
Connected Cardiology to Control Cardiac Rythm
NCT06091514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:
1. ACEI/ARB at discharge for LVSD
2. Assessment of thromboembolic risk factors
3. Beta Blocker at discharge
4. Discharged on FDA-approved anticoagulation therapy
5. PT/INR planned follow-up
6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD.
Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:
1. Aldosterone antagonist at discharge
2. Atrial fibrillation patient education
3. Anticoagulation therapy education
4. CHA2DS2-VASC reported
5. Discharge heart rate \<110bpm
6. Smoking cessation
7. Warfarin at discharge for valvular atrial fibrillation
Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm\_451183.pdf
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GWTG Atrial Fibrillation program
Evidence based recommended therapies and counseling prior to hospital discharge.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients under 18 years of age
* Patients not admitted as inpatients.
* Patients on comfort care only
* Patients discharged to hospice.
18 Years
125 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Javed Butler, MD
Role: PRINCIPAL_INVESTIGATOR
American Heart Association
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amy Bennett
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.